BlackRock’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.2M | Buy |
|
|||||
|
2025
Q1 | $54.1M | Sell |
|
|||||
|
2024
Q4 | $48.3M | Buy |
|
|||||
|
2024
Q3 | $61.6M | Buy |
|
|||||
|
2024
Q2 | $34.8M | Buy |
|
|||||
|
2024
Q1 | $27.2M | Buy |
|
|||||
|
2023
Q4 | $14.5M | Buy |
|
|||||
|
2023
Q3 | $9.7M | Buy |
|
|||||
|
2023
Q2 | $15.1M | Buy |
|
|||||
|
2023
Q1 | $7.28M | Buy |
|
|||||
|
2022
Q4 | $7.71M | Buy |
|
|||||
|
2022
Q3 | $3.84M | Buy |
|
|||||
|
2022
Q2 | $3M | Sell |
|
|||||
|
2022
Q1 | $5.64M | Buy |
|
|||||
|
2021
Q4 | $10.5M | Buy |
|
|||||
|
2021
Q3 | $12.3M | Buy |
|
|||||
|
2021
Q2 | $27.2M | Sell |
|
|||||
|
2021
Q1 | $53.2M | Buy |
|
|||||
|
2020
Q4 | $18.1M | Buy |
|